These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
815 related articles for article (PubMed ID: 8552644)
1. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644 [TBL] [Abstract][Full Text] [Related]
2. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Inobe J; Slavin AJ; Komagata Y; Chen Y; Liu L; Weiner HL Eur J Immunol; 1998 Sep; 28(9):2780-90. PubMed ID: 9754565 [TBL] [Abstract][Full Text] [Related]
3. Oral tolerance to copolymer 1 in myelin basic protein (MBP) TCR transgenic mice: cross-reactivity with MBP-specific TCR and differential induction of anti-inflammatory cytokines. Maron R; Slavin AJ; Hoffmann E; Komagata Y; Weiner HL Int Immunol; 2002 Feb; 14(2):131-8. PubMed ID: 11809732 [TBL] [Abstract][Full Text] [Related]
4. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. Chen Y; Inobe J; Weiner HL J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700 [TBL] [Abstract][Full Text] [Related]
6. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization. Miller A; Zhang ZJ; Sobel RA; al-Sabbagh A; Weiner HL J Neuroimmunol; 1993 Jul; 46(1-2):73-82. PubMed ID: 7689596 [TBL] [Abstract][Full Text] [Related]
7. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA. Bai XF; Shi FD; Xiao BG; Li HL; van der Meide PH; Link H J Neuroimmunol; 1997 Dec; 80(1-2):65-75. PubMed ID: 9413260 [TBL] [Abstract][Full Text] [Related]
8. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Santos LM; al-Sabbagh A; Londono A; Weiner HL Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838 [TBL] [Abstract][Full Text] [Related]
9. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Burkhart C; Liu GY; Anderton SM; Metzler B; Wraith DC Int Immunol; 1999 Oct; 11(10):1625-34. PubMed ID: 10508180 [TBL] [Abstract][Full Text] [Related]
10. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. Khoury SJ; Hancock WW; Weiner HL J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385 [TBL] [Abstract][Full Text] [Related]
11. Immunoregulation of encephalitogenic MBP-NAc1-11-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma. Adlard K; Tsaknardis L; Beam A; Bebo BF; Vandenbark AA; Offner H Autoimmunity; 1999; 31(4):237-48. PubMed ID: 10789989 [TBL] [Abstract][Full Text] [Related]
12. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis. Hafler DA; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Fukaura H Ann N Y Acad Sci; 1997 Dec; 835():120-31. PubMed ID: 9616767 [TBL] [Abstract][Full Text] [Related]
14. Oral administration of cholera toxin B subunit conjugated to myelin basic protein protects against experimental autoimmune encephalomyelitis by inducing transforming growth factor-beta-secreting cells and suppressing chemokine expression. Sun JB; Xiao BG; Lindblad M; Li BL; Link H; Czerkinsky C; Holmgren J Int Immunol; 2000 Oct; 12(10):1449-57. PubMed ID: 11007763 [TBL] [Abstract][Full Text] [Related]
15. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Miller A; Lider O; Roberts AB; Sporn MB; Weiner HL Proc Natl Acad Sci U S A; 1992 Jan; 89(1):421-5. PubMed ID: 1370356 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice. Chen Y; Hancock WW; Marks R; Gonnella P; Weiner HL J Neuroimmunol; 1998 Mar; 82(2):149-59. PubMed ID: 9585811 [TBL] [Abstract][Full Text] [Related]
17. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Chen Y; Kuchroo VK; Inobe J; Hafler DA; Weiner HL Science; 1994 Aug; 265(5176):1237-40. PubMed ID: 7520605 [TBL] [Abstract][Full Text] [Related]
18. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. Whitacre CC; Gienapp IE; Orosz CG; Bitar DM J Immunol; 1991 Oct; 147(7):2155-63. PubMed ID: 1717550 [TBL] [Abstract][Full Text] [Related]
19. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026 [TBL] [Abstract][Full Text] [Related]